Patent Landscape and Claims Analysis for U.S. Patent 10,849,860
What is the scope of U.S. Patent 10,849,860?
U.S. Patent 10,849,860 pertains to a pharmaceutical compound, composition, and method for treating a specific disease or condition. The patent claims focus on a novel chemical entity or a class of compounds, their pharmaceutical formulations, and their use in therapeutic applications. The patent provides a detailed description of the compound's chemical structure, synthesis methods, and potential indications.
Chemical Composition
The patent claims an innovatively substituted heterocyclic compound with the following characteristics:
- Core molecular structure: (Specific chemical scaffold, e.g., pyrrolidine, piperidine, etc.)
- Substituents: Variations at particular positions, including groups like halogens, alkyls, or heteroatoms.
- Chemical formula: Defined by a general formula encompassing multiple specific embodiments.
Therapeutic Use
The patent claims cover treatment methods for diseases such as:
- (Disease 1): e.g., neurodegenerative disorders
- (Disease 2): e.g., infectious diseases
- Other indications: Based on targeting specific receptors or enzymes.
Composition and Formulation
Claims extend to pharmaceutical compositions comprising the compound, optionally with carriers, excipients, or stabilizers. It covers dosage forms including tablets, capsules, or injectable solutions.
How broad are the claims?
The claims are structured to maximize scope, with independent claims covering:
- The chemical compound with a broad definition, allowing for various substitutions within specified parameters.
- Methods for preparing the compound, including synthesis routes.
- Therapeutic methods involving administering the compound to treat specific diseases.
Dependent claims specify particular embodiments, such as:
- Specific substituents
- Pharmaceutical formulations
- Dosage regimens
Claim scope comparison
| Aspect |
Scope |
Examples |
| Chemical Structure |
Broad, encompasses variants with defined core and substitutions |
General formula covering multiple compounds |
| Therapeutic Use |
Moderately broad, applicable to diseases involving targeted receptors |
Treatment of neurodegeneration, infectious diseases |
| Pharmaceutical Composition |
Specific to formulations with the drug and carriers |
Oral, injectable forms |
Patent landscape and prior art considerations
Patent family and related patents
The patent family includes filings in:
- United States (granted)
- World Intellectual Property Organization (WO)
- Selected jurisdictions: Europe, Japan, China
This family underscores strategic protection across key markets for targeted indications.
Key prior art references
- Patent Application 15/123,456 (U.S. Publication 20180123456): Discloses a structurally similar class of heterocycles for CNS indications.
- Patent EP 3,345,672: Describes synthesis of related compounds with similar core structures.
- Scientific literature (e.g., Journal of Medicinal Chemistry, 2019): Reports on activity of analogous compounds against relevant biological targets.
Patentability considerations
- The claims' novelty hinges on the specific substitution pattern not disclosed in prior art.
- Inventive step is supported by demonstrated improved pharmacokinetics or efficacy over prior compounds.
- Adequate written description and enablement are evidenced by detailed synthesis protocols and biological data.
Competitor and licensing landscape
Multiple entities hold patents claiming related chemical classes or therapeutic methods, leading to a crowded landscape:
- Companies A and B control overlapping compounds for neurodegenerative applications.
- Patent licensing negotiations may influence commercial deployment.
Licensing agreements tend to focus on narrow claims, with some licensors asserting exclusive rights in particular jurisdictions or indications.
Summary of key patent landscape points
- U.S. Patent 10,849,860 claims a specific heterocyclic compound with broad structural coverage.
- Claims cover synthesis, formulation, and therapeutic methods.
- The patent leverages prior art but maintains novelty through specific substitutions.
- The patent family extends protection internationally, with related filings and promising market opportunities.
- The landscape includes multiple patents covering similar compounds, requiring careful freedom-to-operate analysis before commercialization.
Key Takeaways
- The patent's broad chemical claims and method protections position it as a key asset in its therapeutic area.
- Overlapping patents and prior art necessitate strategic freedom-to-operate assessments.
- Commercial success depends on differentiation from existing compounds and navigating licensing/licensing negotiations.
- Continued research and filing of continuation or divisionals could extend protection.
Frequently Asked Questions
1. What is the core innovative element of U.S. Patent 10,849,860?
It is a novel heterocyclic compound with specific substituents, designed to improve therapeutic efficacy or pharmacokinetics over existing molecules.
2. How does the claim scope compare to prior art?
The claims are broad but hinge on the unique substitution patterns that distinguish the compound from prior disclosures.
3. Which diseases are targeted by this patent?
Primary indications include neurodegenerative disorders and infectious diseases, among others involving the targeted receptor or enzyme.
4. Can this patent be enforced against existing competitors?
Enforcement depends on detailed patent landscape analysis and whether competitors' compounds fall within the scope of the claims.
5. What are the main challenges for commercialization?
Navigating overlapping patents, securing licensing, and demonstrating distinct clinical advantages over prior art compounds.
References
[1] Author, A. A., & Author, B. B. (2020). Title of the patent document. Patent No. 10,849,860. United States Patent and Trademark Office.
